CIK 0001628171 · Large accelerated filer
Revolution Medicines, Inc.
Sign in to watch- Ticker
- RVMD
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 472029180
- Phone
- 650-481-6801
- Business address
- 700 SAGINAW DR, REDWOOD CITY, CA, 94063
Securities
- RVMD Common Stock Nasdaq
- RVMDW Warrant Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $85,328,124
- in 21 filings, $85.3M under 10b5-1 plans
Net −$85,328,124. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-11 | Kelsey Stephen Michael See Remarks | Sale 10b5-1 | −800 | $198.55 | $159K | 383,607 |
| 2026-09-11 | Kelsey Stephen Michael See Remarks | Sale 10b5-1 | −11,833 | $200.11 | $2.4M | 371,774 |
| 2026-09-11 | Kelsey Stephen Michael See Remarks | Sale 10b5-1 | −13,368 | $200.78 | $2.7M | 358,406 |
| 2026-09-11 | Kelsey Stephen Michael See Remarks | Sale 10b5-1 | −21,447 | $201.75 | $4.3M | 336,959 |
| 2026-09-11 | Kelsey Stephen Michael See Remarks | Sale 10b5-1 | −18,869 | $203.06 | $3.8M | 318,090 |
| 2026-09-11 | Kelsey Stephen Michael See Remarks | Sale 10b5-1 | −17,949 | $203.87 | $3.7M | 300,141 |
| 2026-09-11 | Kelsey Stephen Michael See Remarks | Sale 10b5-1 | −4,995 | $204.84 | $1.0M | 295,146 |
| 2026-09-11 | Kelsey Stephen Michael See Remarks | Sale 10b5-1 | −3,270 | $205.81 | $673K | 291,876 |
| 2026-09-11 | Kelsey Stephen Michael See Remarks | Option exercise · Stock Option (Right to Buy) 10b5-1 | −52,500 | $42.45 | $2.2M | 0 |
| 2026-09-11 | Kelsey Stephen Michael See Remarks | Option exercise · Stock Option (Right to Buy) 10b5-1 | −40,031 | $40.74 | $1.6M | 88,069 |
| 2026-09-10 | Mancini Anthony See Remarks | Option exercise 10b5-1 | +9,363 | $33.62 | $315K | 59,338 |
| 2026-09-10 | Mancini Anthony See Remarks | Sale 10b5-1 | −6,019 | $203.28 | $1.2M | 53,319 |
| 2026-09-10 | Mancini Anthony See Remarks | Sale 10b5-1 | −5,530 | $204.14 | $1.1M | 47,789 |
| 2026-09-10 | Mancini Anthony See Remarks | Sale 10b5-1 | −2,420 | $205.05 | $496K | 45,369 |
| 2026-09-10 | Mancini Anthony See Remarks | Sale 10b5-1 | −1,179 | $206.10 | $243K | 44,190 |
| 2026-09-10 | Mancini Anthony See Remarks | Sale 10b5-1 | −300 | $207.17 | $62K | 43,890 |
| 2026-09-10 | Mancini Anthony See Remarks | Option exercise · Stock Option (Right to Buy) 10b5-1 | −9,363 | 96,746 | ||
| 2026-09-08 | Kim Lorence H. Director | Sale 10b5-1 | −706 | $206.60 | $146K | 16,384 |
| 2026-09-08 | Kim Lorence H. Director | Sale 10b5-1 | −999 | $207.33 | $207K | 15,385 |
| 2026-09-08 | Kim Lorence H. Director | Sale 10b5-1 | −3,587 | $208.55 | $748K | 11,798 |
Page 4 of 18 · 352 trades